Articles > Popular publications > Business Wire press releases > January-March 2008 > Tuesday, January 29

Article: HemoBioTech, Inc. Updates Financial and Media News.

Article from:
Business Wire
Article date:
January 29, 2008
Copyright

Company Highlights Recent Developments

DALLAS -- HemoBioTech, Inc. (OTCBB: HMBT, http://www.hemobiotech.com) a biopharmaceutical company focused on developing and commercializing the first viable human blood substitute with their bovine hemoglobin-based solution, HemoTech, provides an update on recent media and financial news.

* HemoBioTech, Inc. Participates in The McCuistion Program On Human Blood Shortage, January 25, 2008: Chairman & CEO Dr. Arthur P. Bollon appeared as one of the panelists on The McCuistion Program. The syndicated program aired Sunday, January 27, 2008 at 12:30PM(CST) on the Dallas-Fort Worth KERA-Public Television, Channel 13. The ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: HemoBioTech, Inc. Participates in The McCuistion Program ...
Business Wire;  January 25, 2008 ;     700+ words ... ... potential solutions. HemoBioTech's core product ... safe and inexpensive human blood substitute product ... National experts. About HemoBioTech, Inc. HemoBioTech is working on the ... HemoTech, a novel human blood substitute technology ...

Article: HemoBioTech, Inc. Participates in the McCuistion Program ...
Health & Medicine Week;  February 4, 2008 ;     568 words ... ... Army Surgeon General and HemoBioTech Director; and Dr. John ... its potential solutions. HemoBioTech's core product, HemoTech ... for a safe and inexpensive human blood substitute product. "We ... Dr. Bollon. Keywords: HemoBioTech, Inc. This article was ...

Article: HemoBioTech Engages CRO to Facilitate Clinical Study in ...
PR Newswire;  June 21, 2007 ;     700+ words ...'HemoBioTech is developing ... substitute for human blood, licensed ... in India. HemoBioTech is developing ... substitute for human blood -- HemoTech ... for donated human blood. HemoTech ... be due to HemoBioTech's proprietary ...

Article: HemoBioTech's Human Blood Substitute, ...
Business Wire;  November 20, 2007 ;     700+ words ... ... http://www.hemobiotech.com), HemoTech ... viable substitute for human blood, was highlighted ... SciAm.com. About HemoBioTech, Inc. HemoBioTech is working on the ... HemoTech, a novel human blood substitute technology ...

Article: HemoBioTech Expands Sponsored Research Agreement With ...
PR Newswire;  January 31, 2007 ;     700+ words ... ... R&D and Advisor for HemoBioTech, is of major value in this important program." About HemoBioTech, Inc. HemoBioTech is engaged in the development of HemoTech(TM), a novel human blood substitute technology exclusively ...

Article: HemoBioTech Announces Expansion of Facilities.
PR Newswire;  February 1, 2007 ;     700+ words ... ... facilities as we grow HemoBioTech and address the need ... viable substitute for human blood," said Dr. Arthur ... Executive Officer. About HemoBioTech, Inc. HemoBioTech is engaged in the ... TM), a novel human blood substitute technology ...

Article: HemoBioTech Chairman and CEO, Dr. Arthur Bollon, to Give ...
Business Wire;  July 31, 2007 ;     700+ words ... ... further information. HemoBioTech is developing what ... viable substitute for human blood--HemoTech ... competitors. About HemoBioTech, Inc. HemoBioTech is engaged in the ... HemoTech, a novel human blood substitute technology ...

Article: HemoBioTech Featured on Fox News.
Business Wire;  March 26, 2008 ;     700+ words ... ... the first viable human blood substitute, was ... nationally on Fox News. HemoBioTech was featured on Fox ... marketplace." About HemoBioTech, Inc. HemoBioTech is engaged in the ... HemoTech, a novel human blood substitute technology ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives